178 patents
Page 6 of 9
Utility
Scalable three-dimensional elastic construct manufacturing
23 Nov 20
Tissue repair and restoration can be performed using an elastic material formed from tropoelastin.
Anthony Steven Weiss, Suzanne Marie Mithieux
Filed: 9 Dec 13
Utility
Cenicriviroc for the Treatment of Fibrosis
18 Nov 20
The disclosure includes the use of cenicriviroc or a salt or solvate thereof and pharmaceutical compositions containing the same in the treatment of inflammation and connective tissue diseases and disorders, such as fibrosis, peritonitis, and liver injury.
Eric Lefebvre
Filed: 2 Jun 20
Utility
Injection Paradigm for Administration of Botulinum Toxins
18 Nov 20
Disorders such as headaches can be treated by administration of a botulinum toxin to a patient suffering therefrom, such as a migraine headache.
Andrew M. Blumenfeld, Mitchell F. Brin
Filed: 2 Aug 20
Utility
Implant Identification by Radiographic Means
11 Nov 20
A breast implant includes a flexible shell having an anterior face including an outer surface and an inner surface, and a marker attached to the inner surface of the anterior face of the shell.
David J. SCHUESSLER, Alberto FLORES-PUJOL, Daniela RODRIGUEZ-ESTRADA
Filed: 7 May 20
Utility
Cross Linked Silk-hyaluronic Acid Composition
11 Nov 20
Compositions useful as dermal fillers and methods using such compositions to treat various skin and soft tissue conditions.
Elizabeta PAVLOVIC, Monica A. SERBAN, Xiaojie YU, Nicholas J. MANESIS
Filed: 23 Jul 20
Utility
Methods of Scar Prevention And/or Treatment
4 Nov 20
The disclosure relates to methods of treating and/or preventing scarring that would otherwise result from an incision to an area of skin.
Robert DANIELS, Damien BATES, John St. Clair ROBERTS
Filed: 1 May 20
Utility
Oil-in-water Method for Making Polymeric Implants Containing a Hypotensive Lipid
4 Nov 20
Biocompatible microparticles include an ophthalmically active cyclic lipid component and a biodegradable polymer that is effective, when placed into the subconjunctival space, in facilitating release of the cyclic lipid component into the anterior and posterior segments of an eye for an extended period of time.
James Chang, Patrick Hughes, Chin-Ming Chang
Filed: 5 Dec 19
Utility
Scalable Three-dimensional Elastic Construct Manufacturing
4 Nov 20
Tissue repair and restoration can be performed using an elastic material formed from tropoelastin.
Anthony Steven WEISS, Suzanne Marie MITHIEUX
Filed: 22 Jul 20
Utility
Thread insertion devices
2 Nov 20
Devices and methods for inserting an implant into skin or other tissue of a patient can include a hyaluronic thread that is coupled at along distal portion with an insertion device.
Antoine Duc, Bastien Mandaroux
Filed: 23 Jan 17
Utility
Implantable Prostheses for Tissue Expansion
28 Oct 20
A method of manufacturing a tissue expander for implanting into a body of a living subject can include mixing granules of a solute with an elastomer.
David J. SCHUESSLER, Steven A. SCHULTZ
Filed: 12 Jul 20
Utility
Methods of Treating Alpha Adrenergic Mediated Conditions
21 Oct 20
Described herein are compounds for and methods of treating conditions or diseases in a subject by administering to the subject a pharmaceutical composition containing an effective amount of an α-adrenergic modulator.
Daniel W. Gil, John E. Donello, Wenkui K. Fang, Phong X. Nguyen, Ken Chow, Todd M. Heidelbaugh, Dario G. Gomez, Michael E. Garst, Santosh C. Sinha
Filed: 24 Nov 19
Utility
Method to Manufacture a Stable Protein
21 Oct 20
A Clostridial toxin pharmaceutical composition comprising a Clostridial toxin, such as a botulinum toxin, wherein the Clostridial toxin present in the pharmaceutical composition is stabilized by a non-protein excipient such as a polyvinylpyrrolidone, a disaccharide, a trisaccharide, a polysaccharide, an alcohol, a metal, an amino acid, a surfactant and/or a polyethylene glycol.
Terrence J. Hunt
Filed: 30 Jun 20
Utility
GENE SILENCING IN SKIN USING SELF-DELIVERY siRNA DELIVERED BY A MESO DEVICE
21 Oct 20
The present invention is drawn to a low-cost “meso” device that is able to effectively deliver functional self-delivery siRNA to subject and inhibit expression of a gene in the subject as well as related methods.
Roger L. Kaspar, Tycho Speaker
Filed: 29 Jun 20
Utility
Dual cap system for container-closures to maintain tip sterility during shelf storage
19 Oct 20
A container-closure system includes a container configured to hold a therapeutic liquid and having a dispensing tip configured to dispense a dose of the therapeutic liquid.
Sai Shankar
Filed: 25 Jul 13
Utility
Use of agonists of formyl peptide receptor 2 for treating dermatological diseases
12 Oct 20
The present invention relates to a method for treating dermal inflammation and dermal diseases by local or systemic delivery, in a subject in need of such treatment, which comprises administering a pharmaceutical composition comprising a therapeutically effective amount of at least one agonist of Formyl peptide receptor 2 (FPR2).
Veena Viswanath, Richard L. Beard, John E. Donello, Edward Hsia
Filed: 9 Sep 19
Utility
Imidazole derivatives as formyl peptide receptor modulators
12 Oct 20
The present invention relates to imidazole derivatives, processes for preparing them, pharmaceutical compositions containing them and their use as pharmaceuticals as modulators of the N-formyl peptide receptor.
Richard L. Beard, Tien T. Duong, Michael E. Garst
Filed: 21 May 19
Utility
Dissolvable Microneedles for Skin Treatment
7 Oct 20
A skin treatment can include applying a microneedle device to a region of the skin so that microneedles of the device penetrate the stratum corneum.
Justin J. Schwab, Michael Augarten, Zachary Dominguez, Ethan Franklin, Edwin J. Kayda, Jason Metzner
Filed: 29 Mar 20
Utility
Preparation of Bile Acids and Intermediates Thereof
7 Oct 20
Synthetic methods for preparing deoxycholic acid and intermediates thereof are provided.
Achampeta Rathan Prasad, Roy A. Swaringen, JR., John Gregory Reid, Robert M. Moriarty, Akhila Kumar Sahoo
Filed: 22 Apr 20
Utility
COMPLEMENT FACTOR Bb ANTIBODIES
7 Oct 20
The present disclosure relates to antibodies and polynucleotides encoding the same, which may be used to prevent, control, or reduce the activity of the complement pathway.
Yanbin Liang, Chen Li, Iris Lee, Victor M. Guzman
Filed: 26 Mar 20
Utility
Preservative free brimonidine and timolol solutions
5 Oct 20
The present invention is directed to preservative-free solutions of brimonidine and timolol for lowering intra-ocular pressure and treatment of glaucoma.
Sukhon Likitlersuang, Ajay Parashar, Chetan P. Pujara, William F. Kelly
Filed: 9 Jan 19